AAL Shorts at Year High as Analysts Cut Into Earnings
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
American Airlines reports third-quarter results today with short sellers holding their largest position in at least a year, even as the stock recovered ground this week that most of its peers lost.
Short interest reached 99 million shares as of October 20, equal to 15% of the free float. That is up 20% over the past week and 22% over the past month, a build that has accelerated rather than paused into the reporting date. The ORTEX short score has moved to 55.1, its highest reading in the tracked window, up from 50.1 two weeks ago. The travel in that score matters: it has shifted from neutral to a level reflecting sustained directional conviction. Options positioning adds to the picture. The put/call ratio jumped to 1.71 on October 21, nearly three standard deviations above its 20-day average of 1.49, the most defensive options skew in months. Neither the borrow market nor the cost of maintaining a short offers bears any reason to cover: availability is around 404%, meaning roughly four shares are free to borrow for each one already shorted, and borrowing costs have actually eased to 0.39%, down 9% on the week.
The analyst community has spent October cutting targets with near-uniformity. UBS maintained its Buy but lowered its target to $16 on October 16. Goldman Sachs, which carries a Sell, dropped its target to $11 on October 2. Wells Fargo, Barclays, Susquehanna, Evercore and BMO all trimmed targets through September and October while keeping existing ratings intact. The consensus mean target is $15.88, implying meaningful upside from the $12.24 close, but the direction of travel on targets has been one-way. The bear case centres on cost pressure and balance sheet strain: the price-to-book ratio is deeply negative, and EPS momentum ranks in the bottom 5th percentile over both 30 and 90 days, meaning near-term estimate revisions have been running against the stock. The bull case rests on forward earnings recovery, where the 12-month forward EPS growth estimate ranks in the 67th percentile, and on the stock's history of beating expectations, which ranks in the 97th percentile on EPS surprise.
The divergence with peers this week is worth noting. AAL gained 3.8% over the past seven days. DAL fell 3.7%, UAL dropped 5.3%, ALK lost 9.1%, and JBLU fell 13.1%. The contrast is sharper than usual: the airline sector was broadly under pressure, yet AAL moved the other way. PRIMECAP Management, the largest institutional holder at roughly 10.5% of shares, added 21.7 million shares in its last reported period. Orbis Investment Management and Appaloosa Management both appear as fresh or significantly expanded positions as of June 30. That institutional buying sits alongside the heaviest short position of the past year, which means the stock carries genuine two-way conviction.
Today's print is a test of whether the recovery in forward earnings estimates reflects real operating improvement or simply base effects from a depressed prior year.
Stocks in this article
See the live data behind this article on ORTEX.
Open AAL on ORTEX →How this article was generated
- Generated
- 22 Oct 2026, 04:19
- Data as of
- 22 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.